Responses
Oncology
Original research
Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study
Compose a Response to This Article
Other responses
No responses have been published for this article.